Literature DB >> 26708311

Effects of CD73 on human colorectal cancer cell growth in vivo and in vitro.

Ruimin Wu1, Yijia Chen1, Fuyan Li1, Wei Li1, Hong Zhou1, Yi Yang1, Zhijun Pei1.   

Abstract

The purpose of the present study was to explore the role and mechanism of extracellular ecto-5'-nucleotidase (CD73) in human colorectal cancer growth. Firstly, CD73 expression was detected in colorectal cancer cell lines both at the mRNA and protein levels. Secondly, recombinant CD73 interference and overexpression lentiviruses were used, respectively. Colony formation assay, CCK-8 assay and flow cytometry were used to investigate the impact of CD73 on colorectal cancer cell proliferation and cell cycle distribution. Then, adenosine and CD73 enzyme activity inhibitor (APCP) were used to study the effect of CD73 on Epidermal growth factor receptor (EGFR) and β-catenin/cyclin D1 signaling pathways. Finally, a human colorectal cancer transplantation nude mouse model was used to observe the effect of CD73 on tumor growth in vivo. As the results showed, CD73 was highly expressed in the colorectal cancer cell lines. CD73 promoted colorectal cancer cell proliferation both in vivo and in vitro. CD73 activated EGFR and the β-catenin/cyclin D1 signaling pathways through its enzyme and non-enzyme activities. All of the results confirmed that CD73 promotes the growth of human colorectal cancer cells through EGFR and the β-catenin/cyclin D1 signaling pathway. CD73 may be used as a valuable biomarker of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26708311     DOI: 10.3892/or.2015.4512

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  20 in total

1.  Upregulation of CD73 Confers Acquired Radioresistance and is Required for Maintaining Irradiation-selected Pancreatic Cancer Cells in a Mesenchymal State.

Authors:  Anna M Nguyen; Jianhong Zhou; Brihget Sicairos; Sangeetha Sonney; Yuchun Du
Journal:  Mol Cell Proteomics       Date:  2019-12-26       Impact factor: 5.911

2.  CD73 promotes cervical cancer growth via EGFR/AKT1 pathway.

Authors:  Chong Liu; Zhao-Wei Gao; Xi Wang; Fang Lin; Hui-Zhong Zhang; Ke Dong
Journal:  Transl Cancer Res       Date:  2022-05       Impact factor: 0.496

3.  Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation.

Authors:  Octavia Cadassou; Muhammad-Zawwad Raza; Christelle Machon; Laura Gudefin; Célia Armanet; Kamel Chettab; Jérôme Guitton; Maria Grazia Tozzi; Charles Dumontet; Emeline Cros-Perrial; Lars Petter Jordheim
Journal:  Cell Oncol (Dordr)       Date:  2020-09-24       Impact factor: 6.730

4.  Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy.

Authors:  Ryuma Tokunaga; Shu Cao; Madiha Naseem; Jae Ho Lo; Francesca Battaglin; Alberto Puccini; Martin D Berger; Shivani Soni; Joshua Millstein; Wu Zhang; Sebastian Stintzing; Fotios Loupakis; Chiara Cremolini; Volker Heinemann; Alfredo Falcone; Heinz-Josef Lenz
Journal:  Clin Colorectal Cancer       Date:  2018-09-13       Impact factor: 4.481

Review 5.  The Role of NcRNAs to Regulate Immune Checkpoints in Cancer.

Authors:  Yicun Jiang; Leilei Zhao; Yiwen Wu; Sijun Deng; Pu Cao; Xiaoyong Lei; Xiaoyan Yang
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

6.  CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer.

Authors:  Jianjie Zhu; Yuanyuan Zeng; Wei Li; Hualong Qin; Zhe Lei; Dan Shen; Dongmei Gu; Jian-An Huang; Zeyi Liu
Journal:  Mol Cancer       Date:  2017-02-03       Impact factor: 27.401

7.  Ecto-5'-nucleotidase (CD73) is a biomarker for clear cell renal carcinoma stem-like cells.

Authors:  Lei Song; Wenling Ye; Yong Cui; Jianzhong Lu; Yanan Zhang; Nan Ding; Wentao Hu; Hailong Pei; Zhongjin Yue; Guangming Zhou
Journal:  Oncotarget       Date:  2017-05-09

8.  CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.

Authors:  Zhao-Wei Gao; Hui-Ping Wang; Fang Lin; Xi Wang; Min Long; Hui-Zhong Zhang; Ke Dong
Journal:  BMC Cancer       Date:  2017-02-15       Impact factor: 4.430

Review 9.  Targeting CD73 to augment cancer immunotherapy.

Authors:  Meejeon Roh; Derek A Wainwright; Jennifer D Wu; Yong Wan; Bin Zhang
Journal:  Curr Opin Pharmacol       Date:  2020-08-07       Impact factor: 5.547

10.  CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells.

Authors:  Michela Lupia; Francesca Angiolini; Giovanni Bertalot; Stefano Freddi; Kris F Sachsenmeier; Elisa Chisci; Barbara Kutryb-Zajac; Stefano Confalonieri; Ryszard T Smolenski; Roberto Giovannoni; Nicoletta Colombo; Fabrizio Bianchi; Ugo Cavallaro
Journal:  Stem Cell Reports       Date:  2018-03-15       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.